CDXC Historical PE Ratio image   This CDXC PE ratio history page last updated 8/12/2022
CDXC Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/10/2022
2.06-0.09-0.36NA
Q1 2022
5/12/2022
1.64-0.11-0.44NA
Q4 2021
3/9/2022
2.72-0.08-0.32NA
Q3 2021
11/3/2021
6.55-0.13-0.52NA
Q2 2021
8/3/2021
8.73-0.08-0.32NA
Q1 2021
5/6/2021
8.58-0.12-0.48NA
Q4 2020
3/10/2021
10.75-0.10-0.40NA
Q3 2020
11/4/2020
4.78-0.07-0.28NA
Q2 2020
8/6/2020
4.92-0.06-0.24NA
Q1 2020
5/11/2020
5.46-0.10-0.40NA
Q4 2019
3/10/2020
3.43-0.11-0.44NA
Q3 2019
11/12/2019
2.83-0.12-0.48NA
Q2 2019
8/7/2019
4.37-0.10-0.40NA
Q1 2019
5/9/2019
4.74-0.15-0.60NA
Q4 2018
3/7/2019
3.43-0.15-0.60NA
Q3 2018
11/7/2018
3.70-0.16-0.64NA
Q2 2018
8/9/2018
4.91-0.15-0.60NA
Q1 2018
5/10/2018
3.70-0.15-0.60NA
Q4 2017
3/8/2018
5.16-0.17-0.68NA
Q3 2017
11/9/2017
4.89-0.05-0.20NA
Q2 2017
8/10/2017
2.91-0.05-0.20NA
Q1 2017
5/11/2017
3.46-0.05-0.20NA
Q4 2016
3/16/2017
3.01-0.06-0.24NA
Q3 2016
11/10/2016
2.79-0.03-0.12NA
Q2 2016
8/11/2016
4.390.010.04109.7
Q1 2016
5/12/2016
4.900.010.04122.5
Q4 2015
3/17/2016
4.80-0.02-0.08NA
Q3 2015
11/12/2015
4.470.010.04111.7
Q2 2015
8/13/2015
3.420.000.00NA
Q1 2015
5/14/2015
3.96-0.01-0.04NA
CDXC PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/10/2022
2.06-0.09-0.41NA
Q1 2022
5/12/2022
1.64-0.11-0.40NA
Q4 2021
3/9/2022
2.72-0.08-0.41NA
Q3 2021
11/3/2021
6.55-0.13-0.43NA
Q2 2021
8/3/2021
8.73-0.08-0.37NA
Q1 2021
5/6/2021
8.58-0.12-0.35NA
Q4 2020
3/10/2021
10.75-0.10-0.33NA
Q3 2020
11/4/2020
4.78-0.07-0.34NA
Q2 2020
8/6/2020
4.92-0.06-0.39NA
Q1 2020
5/11/2020
5.46-0.10-0.43NA
Q4 2019
3/10/2020
3.43-0.11-0.48NA
Q3 2019
11/12/2019
2.83-0.12-0.52NA
Q2 2019
8/7/2019
4.37-0.10-0.56NA
Q1 2019
5/9/2019
4.74-0.15-0.61NA
Q4 2018
3/7/2019
3.43-0.15-0.61NA
Q3 2018
11/7/2018
3.70-0.16-0.63NA
Q2 2018
8/9/2018
4.91-0.15-0.52NA
Q1 2018
5/10/2018
3.70-0.15-0.42NA
Q4 2017
3/8/2018
5.16-0.17-0.32NA
Q3 2017
11/9/2017
4.89-0.05-0.21NA
Q2 2017
8/10/2017
2.91-0.05-0.19NA
Q1 2017
5/11/2017
3.46-0.05-0.13NA
Q4 2016
3/16/2017
3.01-0.06-0.07NA
Q3 2016
11/10/2016
2.79-0.03-0.03NA
Q2 2016
8/11/2016
4.390.010.01439.0
Q1 2016
5/12/2016
4.900.010.00NA
Q4 2015
3/17/2016
4.80-0.02-0.02NA
Q3 2015
11/12/2015
4.470.01NANA
Q2 2015
8/13/2015
3.420.00NANA
Q1 2015
5/14/2015
3.96-0.01NANA
Quotes delayed 20 minutes

Email EnvelopeFree CDXC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ChromaDex (CDXC) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CELC PE Ratio History
CEMI PE Ratio History
CERC PE Ratio History
CERS PE Ratio History
CFMS PE Ratio History
CFRX PE Ratio History
CGEM PE Ratio History
CHE PE Ratio History
CHMA PE Ratio History
CHRS PE Ratio History
How should the CDXC historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like ChromaDex. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CDXC Historical PE Ratio page.

What is the average historical PE for CDXC based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CDXC historical PE ratio using the annualized quarterly earnings method works out to 114.6.

What is the average historical PE for CDXC based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CDXC historical PE ratio using the TTM earnings method works out to 439.0.

On this page we presented the CDXC Historical PE Ratio information for ChromaDex' stock. The average CDXC historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 114.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CDXC historical PE based on this TTM earnings result method is 439.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CDXC historical PE result, against the recent PE: when this page was posted on 8/11/2022, the most recent closing price for CDXC had been 1.66, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to 0.01. From these numbers, we calculate the recent CDXC PE on 8/11/2022 based on annualized quarterly EPS was 41.5. Based on CDXC's history, that recent PE is low relative to the historical average, with the recent PE 63.8% lower than the historical average PE across our data set for ChromaDex. Looking at the recent CDXC PE on 8/11/2022 based on TTM EPS, we calculate the ratio at 166.0. Based on CDXC's history, that recent PE is low relative to the historical average, with the recent PE 62.2% lower than the average PE across our ChromaDex data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on CDXC or any other given stock, valuation analysis for CDXC can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate ChromaDex PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CDXC. Thanks for visiting, and the next time you need to research CDXC Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding ORPH, Funds Holding KNGS, LSCC Average Annual Return.

 

CDXC Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.